Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 02/05/2018.
Pour ce comité technique, l’ordre de passage des dossiers sera comme suit .
Spécialités Pharmaceutiques fabriquées localement :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme | Présentation | Type de demande | Date Courrier | VEIC | Titulaire |
1 | TIOTROPIUM EASY FLOW | TIOTROPIUM | 18 mcg | Poudre pour inhalation buccale | B/30 gélules + inhalateur | N | Surseoir CTSP 04/04/2018 | E | OPALIA PHARMA |
2 | BIVAL | Valsartan+ Hydrochlorothiazide |
320 mg/25 mg | Comprimé pelliculé | B/28 | N | Surseoir CTSP 04/04/2018 | E | PHILADELPHIA PHARMA |
3 | PAINOFEN PLUS | IBUPROFENE+PHENYLEPHRINE | 200 mg /10 mg | Comprimé pelliculé | B/20 | N | 10/04/2018 | E | OPALIA PHARMA |
4 | APHRODIS | TADALAFIL | 10 mg | Comprimé pelliculé | B/16 | N | 12/04/2018 | C | PHARMACARE |
5 | NORACTONE | SPIRINOLACTONE | 50 MG | Comprimé pelliculé sécable | B/30 | N | 12/04/2018 | E | SAIPH |
6 | LEXIN | CEFALEXINE | 1 gr | Comprimé pelliculé | B/12 | N | 14/04/2018 | E | MEDICEF |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme | Présentation | Type de demande | Date Courrier/BA | VEIC | Titulaire |
1 | STELAR | ESOMEPRAZOLE | 10 mg | Granulés pour suspension buvab | B/14 | N | 07/03/2018 | E | PHILADELPHIA PHARMA |
2 | AZIX | AZITHROMYCINE | 1500/37.5 ml | Poudre pour suspension orale | FL/37.5 ML | N | 30/03/2018 | E | PHARMAGHREB |
3 | NOSPASM | PHLOROGLUCINOL | 80 mg | Comprimé orodispersible | B/20 | N | 30/03/2018 | I | GALPHARMA |
4 | NOSPASM | PHLOROGLUCINOL | 80 mg | Comprimé orodispersible | B/30 | N | 30/03/2018 | I | GALPHARMA |
5 | MOPRAL | OMEPRAZOLE | 20 mg | Gélule | FL/14 | V | 03/04/2018 | E | ADWYA |
6 | VERMOX | MEBENDAZOLE | 100/5ML | Suspension buvable | FL/30ML | V | 03/04/2018 | E | PHARMAGHREB |
7 | ARTICAINE MEDIS ADRÉNALINÉE | ARTICAINE+ ADRENALINE | 1/100 000 | Solution injectable | B/50/1.8 ml | N | 04/04/2018 | E | MEDIS |
8 | CALCIFAST | CALCIUM | 500 mg | Comprimé à croquer | B/30 | N | 04/04/2018 | E | WEST PHARMA |
9 | ORELOX | CEFPODOXIME | 100 mg | Comprimé pelliculé | B/10 | V | 14/04/2018 | E | SANOFI AVENTIS PHARMA TUNISIE |
10 | ORELOX | CEFPODOXIME | 100 mg | Comprimé pelliculé | B/20 | V | 14/04/2018 | E | SANOFI AVENTIS PHARMA TUNISIE |
11 | ORELOX ENFANTS ET NOURRISSONS | CEFPODOXIME | 40 mg/5 ml | Granulés pour suspension buvab | FL/50 ml | V | 14/04/2018 | E | SANOFI AVENTIS PHARMA TUNISIE |
12 | ORELOX ENFANTS ET NOURRISSONS | CEFPODOXIME | 40 MG/5ML | Granulés pour suspension buvab | FL/100 ml | V | 14/04/2018 | E | SANOFI AVENTIS PHARMA TUNISIE |
13 | THERAZID | GLICLAZIDE | 30 mg | Comprimé à libération modifiée | B/30 | N | 16/04/2018 | E | THERA |
14 | THERAZID | GLICLAZIDE | 30 mg | Comprimé à libération modifiée | B/60 | N | 16/04/2018 | E | THERA |
15 | THERAZID | GLICLAZIDE | 30 mg | Comprimé à libération modifiée | B/90 | N | 16/04/2018 | E | THERA |
16 | ALDAZOLE | ALBENDAZOLE | 400 MG | Comprimé pelliculé | B/1 | N | 16/04/2018 | E | TAHA PHARMA |
17 | DOMINAR | CLARITHROMYCINE | 250 mg | Comprimé pelliculé | B/14 | N | 16/04/2018 | E | MEDIS |
18 | DOMINAR | CLARITHROMYCINE | 500 mg | Comprimé pelliculé | B/14 | N | 16/04/2018 | E | MEDIS |
19 | METROJECT | METRONIDAZOLE | 0.5% | Solution injectable | B/25 poches multicouches/100 m | N | 16/04/2018 | E | UNIMED |
20 | PARACETYL ADULTES ET GRANDS EN | PARACETAMOL | 6.5% | Suspension buvable | FL/125 ml | V | 19/04/2018 | E | PHARMADERM |
21 | LASICARE | FUROSEMIDE | 500 mg | Comprimé sécable | B/50 | V | 19/04/2018 | E | PHARMACARE |
22 | OFLOCOL | OFLOXACINE | 0,003 | collyre | FL/5ml | V | CS 27/04/2018 | E | UNIMED |
23 | OFLOCOL | OFLOXACINE | 1,5mg/0,5ml | collyre monodose | B/15 ophtadoses/0,5 ml | V | CS 27/04/2018 | E | UNIMED |
24 | OFLOCOL 3M | OFLOXACINE | 0,003 | collyre | FL/5ml | V | CS 27/04/2018 | E | UNIMED |
Spécialités Pharmaceutiques importées :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | DATE courrier | VEIC | Type de demande |
1 | SURVANTA | BERACTANT | 100mg/4ml | susp,intrachéale | FL/8ML | ABBVIE CORPORATION | 06/03/2018 | C | N |
2 | SURVANTA | BERACTANT | 200mg/8ml | susp,intrachéale | FL/8ML | ABBVIE CORPORATION | 06/03/2018 | C | N |
3 | ALYOSTAL PRICK-TEST CONTRÔLE POSITIF | HISTAMINE HCL | SOLUTION AQUEUSE | FL/3ML | STALLERGENE SA | 08/03/2018 | C | N | |
4 | ALYOSTAL PRICK-TEST TEMOIN NEGATIF | TEMOIN NEGATIF | SOLUTION AQUEUSE | FL/3ML | STALLERGENE SA | 08/03/2018 | C | N | |
5 | ALYOSTAL PRICK | EXTRAIT ALLERGENIQUE | SOLUTION AQUEUSE | FL/3ML | STALLERGENE SA | 08/03/2018 | C | N | |
6 | OZURDEX | DEXAMETHASONE | 700MCG | SOL.INTRAOCULAIRE | B/1 IMPLANT | MEDICIS | 05/04/2018 | E | N |
7 | OLOPAT | OLOPATADINE | 0,001 | COLLYRE | B/1FL/5ML | JAMJOUM PHARMA | 10/04/2018 | E | N |
8 | GIOTRIF | AFATINIB | 20MG | COMPRIME | B/28 | BOEHRINGER GERMANY | 13/04/2018 | V | N |
9 | GIOTRIF | AFATINIB | 30MG | COMPRIME | B/28 | BOEHRINGER GERMANY | 13/04/2018 | V | N |
10 | GIOTRIF | AFATINIB | 40MG | COMPRIME | B/28 | BOEHRINGER GERMANY | 13/04/2018 | V | N |
11 | GIOTRIF | AFATINIB | 50MG | COMPRIME | B/28 | BOEHRINGER GERMANY | 13/04/2018 | V | N |
12 | DROPERIDOL AGUETTANT | DROPERIDOL | 1,25 MG/ML | SOL INJ | B/10/AMPOULES/1ML | AGUETTANT France | 16/04/2018 | E | N |
13 | LIDOCAINE ADRENALINE AGUETTANT | LIDOCAINE ADRENALINE | 10MG/0,05MG | B/10AMPOULES/10ML | AGUETTANT France | 18/04/2018 | E | N | |
14 | LIDOCAINE ADRENALINE AGUETTANT | LIDOCAINE ADRENALINE | 20MG/0,05MG | SOL INJ | B/10AMPOULES/10ML | AGUETTANT France | 18/04/2018 | E | N |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE BA |
1 | PROLUTEX | PROGESTERONE | 25MG | SOL INJ | B/7FL | IBSA SUISSE | V | N | BA09/03/2018 |
2 | MOONIA | DESOGESTREL | 75µG | COMPRIME | B/28 | STRAGEN UK | V | N | BA09/03/2018 |
3 | FLUTIFORM | FLUTICASONE+FORMOTEROL | 125µG/5µG | SUSP. INHAL | B/1FL/120DOSES | NAPP PHARMACEUTICAL | C | N | BA21/03/2018 |
4 | FLUTIFORM | FLUTICASONE+FORMOTEROL | 50µG/5µG | SUSP. INHAL | B/1FL/120DOSES | NAPP PHARMACEUTICAL | N | BA21/03/2018 | |
5 | ALDARA | IMIQUIMOD | 5% | SACHETS | B/12 | MEDA PHARMA | E | BA21/03/2018 | |
6 | HUMIRA | ADALILUMAB | 40MG | SOL.INJECTABLE | B/2SERINGUES/0,4ML | ABBVIE | E | V | CS 03/2018 |
7 | BIOMAG ARGUMES | PRDTS HOMEOPATHIQUES | COMPRIME CROQUER | B/90 | LEHNING | C | V | CS03/2018 | |
8 | OSCILLOCOCCINUM 200 | PRDTS HOMEOPATHIQUES | GRANULES | B/6 | BOIRON | C | V | CS03/2018 | |
9 | OSCILLOCOCCINUM 200 | PRDTS HOMEOPATHIQUES | GRANULES | B/3 | BOIRON | C | V | CS03/2018 | |
10 | MERCURE SOL COMPLEXE N°39 | PRDTS HOMEOPATHIQUES | COMPRIME SUBLINGUAL | B/60 | LEHNING | C | V | CS03/2018 | |
11 | BISEPTINE | BENZALKONIUM+CHLORH | SOLUTION EXTERNE | FL/100ML | BAYER France | C | N | BA 26/03/2018 | |
12 | MONTELUKAST SANDOZ | MONTELUKAST | 5MG | COMPRIME A CROQUER | B/28 | SANDOZ FRANCE | E | N | BA 26/03/2018 |
13 | MONTELUKAST SANDOZ | MONTELUKAST | 10MG | COMPRIME A CROQUER | B/28 | SANDOZ FRANCE | E | N | BA 26/03/2018 |
14 | EYEFILL MB | HYALURONATE DE SODIUM | SOL INTRAOCULAIRE | B/2 SERINGUES | VALENT POLAND | C | N | TRANSFERT AMM 27/03/2018 | |
15 | EYEFILL C | HYALURONATE DE SODIUM | SOL INTRAOCULAIRE | B/2 SERINGUES | VALENT POLAND | C | N | TRANSFERT AMM 27/03/2018 | |
16 | SINUSPAX | COMPRIME A CROQUER | B/60 | LEHNING France | C | V FORMULE | BA 09/2017 | ||
17 | PABAL | CARBETOCINE | 100MCG/ML | SOL INJ | B/5FL | FERRING GMBH | E | N | CS 04/2018 |
18 | VICTOZA | LIRAGLUTIDE | 6MG/ML | SOL INJ | B/2 STYLOS | NOVO NORDISK | V | V | CS 04/2018 |
19 | NATEMILLE | VIT D3 | 600MG/1000UI | COMP ORODISPERSIBLE | B/30 | ITALFARMACO | E | N | CS 04/2018 |
20 | RYZODEG FLEXTOUCH | INSULINE ASPARTATE+INSULINE DEGLUDEC | 100UI/ML | SOL INJ | B/5 STYLOS/3ML | NOVO NORDISK | V | N | CS 04/2018 |
21 | REVOLADE | ELTROMBOPAG | 25MG | COMP PELLICULES | B/28 | NOVARTIS EUROPHARM LIMITED | E | V | CS 04/2018 |
22 | REVOLADE | ELTROMBOPAG | 50MG | COMP PELLICULES | B/28 | NOVARTIS EUROPHARM LIMITED | E | V | CS 04/2018 |
23 | MINIRIN | ACETATE DESMOPRESSINE | 60UG | LYOPHILISAT ORALE | B/30 | FERRING GERMANY | E | N | CS 04/2018 |
24 | OXYNORM | OXYCODONE HCL | 5MG | GELULE | B/56 | NAPP PHARMACEUTICAL | N | 16/04/2018 | |
25 | OXYNORM | OXYCODONE HCL | 10MG | GELULE | B/56 | NAPP PHARMACEUTICAL | N | 16/04/2018 | |
26 | OXYNORM | OXYCODONE HCL | 20MG | GELULE | B/56 | NAPP PHARMACEUTICAL | N | 16/04/2018 | |
27 | ORELOX ENFANT ET NOURISSONS | CEFPODOXIME | 40MG/5ML | GRANULES SUSP ORALE | FL/100ML | SANOFI AVENTIS France | E | V | CS 04/2018 |
28 | ORELOX | CEFPODOXIME | 50MG/5ML | GRANULES SUSP ORALE | FL/50ML | SANOFI AVENTIS France | E | V | CS 04/2018 |
29 | ORELOX | CEFPODOXIME | 100MG | COMPRIME PELLICULE | B/10 | SANOFI AVENTIS France | E | V | CS 04/2018 |
30 | CERVARIX | VACCIN CONTRE PAPILLOMAVIRUS HUMAIN | 20µG/20µG | SUSP.INJ | B/1 SERINGUE PREREMPLIE | GSK | I | V | CS 04/2018 |
31 | MONURIL | FOSFOMYCINE | 3GR | GRANULES SUPS BUVABLE | B/1 SACHET | ZAMBON | E | V | CS 04/2018 |
32 | COLIMYCINE | COLISTINEMETHANESULFONATE SODIQUE | 1000000UI | PDRE SUSP INJ | B/50 | SANOFI AVENTIS France | E | V | CS 04/2018 |
33 | BOOSTRIX | VACCIN DIPHTERIQUE TETANIQUE COQUELUCHEUX | SUSP INJ | B/1 SERINGUE PREREMPLIE | GSK Belgique | E | V | CS 04/2018 | |
34 | IMMUNO HBS | IMMUNOGLOBULINE HUMAINE ANTI HBS | 180 UI | SOL INJ | B/1 FL/1ML | KEDRION SPA | E | V | CS 04/2018 |
35 | IMMUNO HBS | IMMUNOGLOBULINE HUMAINE ANTI HBS | 540UI | SOL INJ | B/1 FL/3ML | KEDRION SPA | E | V | CS 04/2018 |
36 | HEPATITIS B | IMMUNOGLOBULINE HUMAINE ANTI HBS | 200 UI | SOL INJ | B/1 SERINGUE PREREMPLIE | CSL BEHRING GERMANY | E | V | CS 04/2018 |
37 | HEPATITIS B | IMMUNOGLOBULINE HUMAINE ANTI HBS | 200 UI | SOL INJ | B/1 SERINGUE PREREMPLIE | CSL BEHRING GERMANY | E | V | CS 04/2018 |
38 | NIMENRIX | SOL INJ | B/1 SERINGUE PREREMPLIE | PFIZER UK | I | V | CS 04/2018 | ||
39 | LETROZLE MYLAN | LETROZLE | 2,5MG | COMPRIME PELLICULLES | B/30 | MYLAN SAS France | V | N | 18/04/2018 |
40 | LEXAVON | LEVOFLOXACINE | 5MG/ML | COLLYRE | B/1FL | RAFARM SA GRECE | E | N | 18/04/2018 |
41 | DBL GEMCITABINE | GEMCITABINE | 200MG/5,3ML | SOL PERF | B/1FL | HOSPIRA PTY | V | N | 27/04/2018 |
42 | DBL GEMCITABINE | GEMCITABINE | 1GR/26,3ML | SOL PERF | B/1FL | HOSPIRA PTY | V | N | 27/04/2018 |
43 | PMS-PREGABALINE | PREGABALINE | 75MG | GELULE | B/100 | PMS CANADA | V | N | 27/04/2018 |
44 | PMS-PREGABALINE | PREGABALINE | 150MG | GELULE | B/100 | PMS CANADA | V | N | 27/04/2018 |
45 | EYLEA | AFLIBERCEPT | 40MG/ML | SOL,INJ | B/1FL/120DOSES | BAYER Allemagne | V | CS 27/04/2018 | |
46 | SINUSPAX | COMPRIME | B/60 | LEHNING | C | V INDICATION | CS 27/04/2018 |